wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58800533-306C3D1C-7A2F-4D88-A462-5338502F8C84
Q58800533-306C3D1C-7A2F-4D88-A462-5338502F8C84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58800533-306C3D1C-7A2F-4D88-A462-5338502F8C84
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
P2860
Q58800533-306C3D1C-7A2F-4D88-A462-5338502F8C84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58800533-306C3D1C-7A2F-4D88-A462-5338502F8C84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
949c033510e838a56b38cadca8d48f363f462f98
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.